These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 13714420)

  • 1. Effect of the combined administration of imipramine and a monoamine oxidase inhibitor.
    HIMWICH WA; PETERSEN JC
    Am J Psychiatry; 1961 Apr; 117():928-9. PubMed ID: 13714420
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity from large doses of imipramine and an MAO inhibitor in suicidal intent.
    LUBY ED; DOMINO EF
    JAMA; 1961 Jul; 177():68-9. PubMed ID: 13763947
    [No Abstract]   [Full Text] [Related]  

  • 3. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
    ZELLER EA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of monoamine oxidase inhibitors with imipramine and similar drugs.
    HIMWICH WA
    Recent Adv Biol Psychiatry; 1961; 4():257-65. PubMed ID: 13907504
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 6. Response of chronic schizophrenics to a monoamine oxidase inhibitor.
    GUERTIN WH; REGNIER WO; GOOD RW; NICHOLSON G
    Dis Nerv Syst; 1960 Jun; 21():330-2. PubMed ID: 13830070
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with monoamine oxidase inhibitors and other substances controlling serotonin metabolism].
    CONSBRUCH U; FAUST C
    Psychiatr Neurol (Basel); 1960 Jul; 140():76-82. PubMed ID: 13695106
    [No Abstract]   [Full Text] [Related]  

  • 8. Some pharmacological observations on tranylcypromine (SKF trans-385), a potent inhibitor of monoamine oxidase.
    TEDESCHI RE; TEDESCHI DH; AMES PL; COOK L; MATTIS PA; FELLOWS EJ
    Proc Soc Exp Biol Med; 1959 Nov; 102():380-1. PubMed ID: 13837261
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of dopamine beta-oxidase by imipramine.
    GOLDSTEIN M; CONTRERA JF
    Biochem Pharmacol; 1961 Aug; 7():278-9. PubMed ID: 13706656
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A; McGRATH WR
    Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphetamine, diethylpropion and tranylcypromin, a psychopharmacological study in the relation between structure and activity.
    MELANDER B; GLINIECKE G
    Acta Pharmacol Toxicol (Copenh); 1961; 18():239-48. PubMed ID: 14472314
    [No Abstract]   [Full Text] [Related]  

  • 12. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.
    GREEN H; ERICKSON RW
    Arch Int Pharmacodyn Ther; 1962 Feb; 135():407-25. PubMed ID: 13901404
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of imipramine on the 5-hydroxytryptamine content and monoamine oxidase activity of the rat brain and on the excretion of 5-hydroxyindole acetic acid.
    KIVALO E; RINNE UK; KARINKANTA H
    J Neurochem; 1961 Nov; 8():105-8. PubMed ID: 14456582
    [No Abstract]   [Full Text] [Related]  

  • 14. ESCAPE FROM ENERGIZER CONTROL.
    OSTOW M
    JAMA; 1965 Feb; 191():410-2. PubMed ID: 14232450
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of trans-2-phenylcycloproplylamine upon norepinephrine concentration and monamine oxidase activity of rat brain.
    GREEN H; ERICKSON RW
    J Pharmacol Exp Ther; 1960 Jul; 129():237-42. PubMed ID: 13851486
    [No Abstract]   [Full Text] [Related]  

  • 16. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
    LEMERE F
    Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582
    [No Abstract]   [Full Text] [Related]  

  • 17. Calming effect of the monoamine oxidase inhibitors.
    ARNOT R
    Dis Nerv Syst; 1960 Aug; 21():448. PubMed ID: 13794397
    [No Abstract]   [Full Text] [Related]  

  • 18. A monoamine oxidase inhibitor in the treatment of organic disease.
    MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychopharmacology and psychotherapy in the treatment of anxiety.
    Freedman AM
    Curr Psychiatr Ther; 1986; 23():101-18. PubMed ID: 2870877
    [No Abstract]   [Full Text] [Related]  

  • 20. A new and safer monoamine oxidase inhibitor.
    ROBIE TR
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():31-48. PubMed ID: 13742239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.